Director, US BD&L and Commercial Mergers & Integrations

Novartis•East Hanover, NJ
•$176,400 - $327,600

About The Position

The Director, US BD&L will work under the leadership of the ED US BD&L and Commercial Mergers & Integrations to partner with an extended team of US cross-functional experts providing strategic support across therapeutic areas, with a preference for candidates who bring relevant expertise through scientific, clinical, pipeline, commercial, or BD&L experience. This individual will help ensure strong US perspective and alignment across asset assessments, opportunity prioritization, and cross-functional input, while supporting effective partnership with the global team in Strategy and growth (BD&L) as well as the M&A group. The Director, US BD&L will offer strategic support in an agile way, depending on the priorities. This leader is expected to demonstrate accountability and responsibility for broader enterprise leadership in her/his decisions and engagement across the US Pharma organization and the Global Pharma Organization. This leader has a passion for transformational enterprise leadership, decisive strategy in service of delivering higher impact for patients, customers, healthcare systems with higher quality, speed and agility.

Requirements

  • Bachelor’s Degree required; MBA, scientific, clinical, or health policy degree preferred.
  • 8+ years of relevant pharmaceutical industry experience, such as commercial strategy, BD&L, pipeline strategy, insights and analytics, modeling, finance, access, or related functions.
  • Strong understanding of the commercialization process, pipeline assessment, coverage and reimbursement considerations, and cross-functional decision-making.

Nice To Haves

  • Cardiovascular/Cardiology expertise preferred, ideally through scientific, clinical, pipeline, commercial, or BD&L experience.

Responsibilities

  • Coordinate clear and timely US input across TA pipeline leads and relevant line functions to support high-quality BD&L assessments and recommendations.
  • In close collaboration with the data and insights team, integration of insights and recommendation for all sources of external data, including analysts’ reports, enterprise level competitive intelligence
  • Serve as an effective bridge between US stakeholders, Strategy & Growth, TASH, and Global teams to ensure aligned, actionable, and well-integrated US perspectives.
  • Lead cross-TA coverage, with a preferred core focus and deeper expertise in Cardiovascular/Cardiology and related pipeline areas, while remaining flexible and able to integrate knowledge across other therapeutic areas, including Neuroscience, Oncology, and Im-munology, as US BD&L priorities, bandwidth, and business needs evolve.
  • Support merger, acquisition, and integration preparedness by contributing to coordinated US BD&L input, while demonstrating the agility, operational discipline, and people-management skills needed to pivot and support integration work during an acquisition or other priority enterprise initiatives.

Benefits

  • health, life and disability benefits
  • a 401(k) with company contribution and match
  • a variety of other benefits
  • generous time off package including vacation, personal days, holidays and other leaves
© 2026 Teal Labs, Inc
Privacy PolicyTerms of Service